Form 4: Phathom Pharmaceuticals Director Asit Parikh Increases Stake with $44,200 Stock Purchase

Director Asit Parikh of Phathom Pharmaceuticals, Inc. (PHAT) acquired 10,000 shares of common stock at an average price of $4.42 on March 13, 2025, increasing his total holdings to 85,500 shares.

Summary

• On March 13, 2025, Asit Parikh, a director of Phathom Pharmaceuticals, Inc. (PHAT), purchased 10,000 shares of the company's common stock.
• The shares were acquired at a weighted average price of $4.42, with individual transactions ranging from $4.29 to $4.55.
• Following the transaction, Parikh's total beneficial ownership in Phathom Pharmaceuticals increased to 85,500 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director buying shares is generally a good sign, but the transaction is relatively small and doesn't provide a strong signal.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Director stock purchases are common and monitored by investors as an indicator of management's sentiment towards the company's prospects. It's a small transaction and not necessarily indicative of a major trend.

Stakeholder Impact

• The stock purchase could have a minor positive impact on shareholder sentiment.

Key Dates